Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2020 Nov 2.
Published in final edited form as: Neurobiol Aging. 2020 Apr 20;93:25–34. doi: 10.1016/j.neurobiolaging.2020.04.013

Older, non-demented apolipoprotein ε4 carrier males show hyperactivation and structural differences in odor memory regions: a blood-oxygen-level-dependent and structural magnetic resonance imaging study

Eleni A Kapoulea a, Claire Murphy a,b,c,*
PMCID: PMC7605173  NIHMSID: NIHMS1586010  PMID: 32447009

Abstract

The current study sought to examine the interaction of sex and Apolipoprotein ε4 status on olfactory recognition memory within non-demented, older individuals. We separated 39 participants into groups based on ε4 status and sex. Each participant completed an olfactory memory recognition task during 2 functional magnetic resonance imaging scans and 1 structural scan. The ε4 carriers had greater functional recruitment of memory regions during false positives relative to ε4 non-carriers. During hits, the male ε4 carriers showed greater functional recruitment compared to female ε4 carriers. The ε4 carriers had larger bilateral putamen volumes relative to ε4 non-carriers. Neuroimaging data were significantly associated with Dementia Rating Scale scores solely in males. Results suggest differential olfactory memory processing in relation to sex and ε4 status. Male ε4 carriers in particular, demonstrated hyperactivation during recognition memory, which we suspect reflects neuronal compensation to maintain functional performance. Future studies should consider examining underlying mechanisms that contribute to these sex differences within ε4 carriers.

Keywords: Alzheimer’s disease, Apolipoprotein ε4, Olfactory memory, Neuroimaging, Sex

1. Introduction

The presence of the Apolipoprotein (ApoE) ε4 allele is the most well-established genetic risk factor for Alzheimer’s disease (AD), a devastating neurodegenerative disease with no cure (Alzheimer’s Association, 2018; Bu, 2009). In humans, the ApoE gene exists as 3 different polymorphic alleles (ε2, ε3, ε4; Bu, 2009; Farrer et al., 1997; Lind et al., 2006; Yu et al., 2013). Under normal physiological conditions, ApoE supports cholesterol and lipid transport and performs membrane repair processes to protect neuronal integrity (Mahley and Huang, 2012). The ε4 variant generally exhibits poorer cholesterol transport and amyloid-β (Aβ) plaque clearance, as well as increased neurofibrillary tangle formation relative to the ε3 allele (Mahley and Rall, 2000). The accumulation of neurofibrillary Aβ plaques and tau tangles is a pathological marker in AD and associated with cognitive decline (Blennow et al., 2006; Braak and Braak, 1991, 1996; Hedden et al., 2013). These accumulations are often reported in medial temporal lobe (MTL) regions (e.g., entorhinal cortex [ERC], hippocampus), which are areas associated with odor recognition memory (Cerf-Ducastel and Murphy, 2009).

Sex differences in odor identification (odor ID) and AD development have been noted in previous literature. Older women tend to outperform older men in odor ID tasks (Murphy et al., 2002; Wehling et al., 2016). Males’ ability to identify odors may deteriorate earlier (approximately 20 years) in the lifespan relative to females (Ship et al., 1996). The ApoE ε4 allele tends to have a more pronounced effect on late-onset AD development in women compared to men, although some attribute this to women’s longer lifespan (Altmann et al., 2014; Bartrés-Faz et al., 2002; Holland et al., 2013; Hyman et al., 1996; Payami et al., 1996; Poirier et al., 1993; Ungar et al., 2014). Women homozygous for ε4 have a greater risk than heterozygous women, but male homozygous and heterozygous for the ε4 allele do not differ significantly (Payami et al., 1996). Despite the apparent sex differences in AD progression, it is relatively overlooked in the existing literature (Ungar et al., 2014).

Participants with and at-risk for AD have demonstrated poor recognition memory overall, with olfactory recognition memory being the most compromised (Moberg et al., 1987). Individuals at-risk for AD but who have not yet developed clinical dementia demonstrate deficits in olfactory functioning, particularly in olfactory memory, recall, and recognition (Albers et al., 2015; Murphy, 2019; Murphy et al., 1999; Nordin and Murphy, 1996, 2006; Olofsson et al., 2010). Participants with selective odor memory deficits are significantly more likely to possess the ε4 allele (Albers et al., 2016). Odor recognition memory and odor ID are most impaired in ε4 carriers relative to other memory tasks (e.g., picture ID, facial recognition memory; Calhoun-Haney and Murphy, 2005; Gilbert and Murphy, 2004).

The brain regions that are impacted by AD overlap with brain regions that are critical for olfaction. Early projections of the olfactory system involve MTL brain regions that are involved in the encoding and retrieval of episodic memories, such as the ERC and hippocampus (Cerf-Ducastel and Murphy, 2009; Haase et al., 2013). Those with odor memory deficits demonstrate significantly reduced ERC thickness relative to those without deficits (Albers et al., 2016). Atrophy and plaque and tangle accumulation in the MTL are early pathological changes in AD progression (Albers et al., 2015; Attems et al., 2005, 2014; Braak and Braak, 1991, 1996, 1997; Esiri and Wilcock, 1984; Frisoni et al., 2010; Hyman, 1997; Murphy et al., 2003; Price et al., 1991; Stoub et al., 2006; Visser et al., 2002).

Although there are studies exploring neuroimaging data within ε4 carriers and ε4 non-carriers during episodic memory tasks and resting-state functional magnetic resonance imaging (fMRI) (Chen et al., 2015, 2016; Dowell et al., 2016; Filippini et al., 2009; Mondadori et al., 2007; Ungar et al., 2014), information is absent on the interaction of sex and ApoE ε4 status on functional and structural neuroimaging during olfactory recognition memory processing.

In order to fill this gap in the current literature, we examined differential olfactory recognition memory processing within a sample of non-demented, older ApoE ε4 carriers and ε4 non-carriers using structural neuroimaging and blood-oxygen-level-dependent fMRI. We further examined how sex modifies olfactory recognition memory processing within this population.

1.1. Hypotheses

Our first hypothesis is that ε4 carriers will demonstrate significantly less volume and thickness within brain regions associated with olfactory memory, such as the ERC and hippocampus, after adjusting for age and ICV. A second hypothesis is that while all ε4 carriers will demonstrate significantly greater functional activation in brain regions associated with odor memory during FPs and significantly less activation during hits, this activation pattern will be most pronounced in male ε4 carriers. Our third hypothesis is that neuroimaging data will be associated with Dementia Rating Scale (DRS) scores within all groups.

2. Materials and methods

The current study sample was taken from an archival dataset. The Institutional Review Boards both at San Diego State University and the University of California, San Diego had approved the research. The only study published to date on this dataset was Haase et al. (2013) which reported behavioral and functional connectivity analyses.

2.1. Participants

Participants (N = 39) ranged in age from 64 to 88 and were divided into one of the 4 groups based on ε4 status and sex: male ε4 carriers (n = 9), female ε4 carriers (n = 9), male ε4 non-carriers (n = 10), and female ε4 non-carriers (n = 11). ApoE ε4 status was determined through genomic testing. We performed a 2 (ε4 status: carrier, non-carrier) × 2 (sex: male, female) multivariate analysis of variance on demographic variables, which included age, education in years, odor threshold (Murphy et al., 1990), odor ID (San Diego Odor Identification Test; Murphy et al., 2002), or DRS scores, a global measure of cognitive function (Mattis, 1998). There were no significant differences between groups in demographics based on E4 status, sex, or the E4 × sex interaction (p > 0.05; Table 1).

Table 1.

Participant demographics

Demographics Mean (SD)
F Significance
ε4 non-carriers
ε4 carriers

Males (n = 10) Females (n = 11) Males (n = 9) Females (n = 9) ε4 status Sex ε4 × sex
Age (y) 69.6 (3.7) 75 (7.1) 73 (7.7) 72.4 (8.9) 0.04 1.14 1.72 p > 0.05
Education (y) 15.5 (2.3) 15.3 (3.5) 15.8 (3.4) 15.3 (3.5) 0.02 0.09 0.03 p > 0.05
Odor threshold 5.5 (1.8) 5.0 (1.4) 4.4 (1.7) 5.8 (1.6) 0.05 0.85 3.10 p > 0.05
Odor ID 4.7 (1.3) 5.8 (1.4) 5.0 (1.5) 5.0 (1.8) 0.29 1.36 0.25 p > 0.05
DRS 140.6 (2.0) 138.0 (4.1) 139.4 (3.5) 138.8 (5.0) 0.02 1.78 0.44 p > 0.05

Key: DRS, Dementia Rating Scale; SD, standard deviation.

2.2. Neuroimaging procedure

Prior to scanning, participants were presented with 16 familiar odors, in random order, corresponding to the list A of the California Odor Learning Test (Murphy et al., 1997). During the scan, participants were presented with labels of odors and their task was to indicate if the label was an odor that was presented to them prior to the scan (target) or if it was not (foil) using a button box (Cerf-Ducastel and Murphy, 2009, 2006; Haase et al., 2013). Each participant completed 2 functional runs (6 minutes each) and a structural run. Target periods consisted of 7 targets and 2 foils. Foil periods consisted of 7 foils and 2 targets. This paradigm was adapted from Stark and Squire (2000a, 2000b). Participants discriminated between odors using a button box, pressing 1 if they recognized the odor as having been presented before the scan and 2 if not. For the purposes of our current study, we focused on hit (correctly identifying a target as a target) and false positive (FP; incorrectly identifying a foil as a target) responses.

2.3. Imaging acquisition

Functional images were collected first using a standard gradient echo EPI pulse sequence to acquire T2-weighted functional images (30 axial slices, field of view = 25 cm, resolution 4 × 4 × 4 mm3, repetition time = 4 seconds, echo time = 30 ms, flip angle = 90°). Parameters used to acquire structural images were as follows: T1-weighted whole-brain fast spoiled gradient echo magnetic resonance imaging sequence, field of view = 25 cm, resolution = 1 × 1 × 1 mm3, repetition time = 16 seconds, echo time = 4.4 m, flip angle = 18°.

2.3.1. Structural neuroimaging data

T1-weighted structural scans were processed using standard FreeSurfer automated processing procedures within the FreeSurfer image analysis suite, version 5.2.0 (http://surfer.nmr.mgh.harvard.edu; Dale and Sereno, 1993; Fischl and Dale, 2000; Fischl et al., 2001; Fischl et al., 2004a; Fischl et al., 1999a; Dale et al., 1999; Fischl et al., 1999, 2002, 2004; Han et al., 2006; Jovicich et al., 2006; Kuperberg et al., 2003; Reuter et al., 2010, 2012; Reuter and Fischl, 2011; Rosas et al., 2002; Salat et al., 2004; Ségonne et al., 2004, 2007; Sled et al., 1998). Cortical thickness and volumetric estimates of regions of interest were extracted from automatic surface parcellation labels using the Desikan/Killiany Atlas (Desikan et al., 2006).

2.3.2. Functional neuroimaging data

Imaging data were processed using FMRIB Software Library (Analysis Group, FMRIB, Oxford, UK) and Analysis of Functional NeuroImage (open source software), using 3dDeconvolve, on each participant’s concatenated runs based on the specified contrast (e.g., activation during hits and FPs; Cox, 1996; Cox and Hyde, 1997; Gold et al., 1998; Smith et al., 2004; Zald and Pardo, 2000). The output from 3dDeconvolve contains fit coefficients (i.e., beta weights) for each voxel, indicating the amplitude of the signal model for each contrast, and corresponding t-statistics.

2.4. Statistical analyses

2.4.1. Task performance

We performed a 2 (sex: male, female) × 2 (ε4 status: ε4 non-carrier, ε4 carrier) multivariate analysis of covariance (MANCOVA) on the hit rate sand FP rate for the 2 independent runs and their average performance (Table 2). The MANCOVA controlled for age.

Table 2.

Olfactory memory task performance rates

Memory measure Mean (SD)
F (significance)
ε4 non-carriers
ε4 carriers
 
Males (n = 10) Females (n = 11) Males (n = 9) Females (n = 9) ε4 status Sex ε4 × sex
Hit rates
  Run 1 0.42 (0.13) 0.57 (0.11) 0.59 (0.12) 0.64 (0.17) 7.597a (p = 0.01) 4.829a (p = 0.04) 1.390 (p > 0.05)
  Run 2 0.44 (0.17) 0.55 (0.14) 0.53 (0.21) 0.60 (0.15) 2.025 (p > 0.05) 2.234 (p > 0.05) 0.135 (p > 0.05)
FP rates
  Run 1 0.32 (0.15) 0.30 (0.11) 0.36 (0.12) 0.29 (0.09) 0.189 (p > 0.05) 1.27 (p > 0.05) 0.384 (p > 0.05)
  Run 2 0.29 (0.15) 0.30 (0.14) 0.30 (0.16) 0.30 (0.11) 0.018 (p > 0.05) 0.012 (p > 0.05) 0.002 (p > 0.05)

Covariates appearing in the model are evaluated at the following values: age = 72.56.

Key: FP, false positives; SD, standard deviation.

a

Denotes significance.

2.4.2. Structural neuroimaging data

We performed a 2 (sex: male, female) × 2 (ε4 status: ε4 non-carrier, ε4 carrier) MANCOVA on left/right hippocampal volumetric and left/right ERC thickness measurements (Table 3). The MANCOVA controlled for age and intracranial volume (ICV).

Table 3.

Hippocampal volume (mm3) and entorhinal cortex thickness (mm)

Structural measurements Mean (SD)
F (significance)
ε4 non-carriers
ε4 carriers
 
Males (n = 10) Females (n = 11) Males (n = 9) Females (n = 9) ε4 status Sex ε4 × sex
Left hippocampus (mm3) 2897.30 (869.75) 2957.45 (396.96) 2742.11 (656.94) 3400.44 (519.24) 0.16 (p > 0.05) 5.76a (p = 0.02) 0.949 (p > 0.05)
Right hippocampus
(mm3)
2923.40 (649.00) 3240.64 (538.18) 2994.78 (569.51) 3507.33 (462.88) 1.263 (p > 0.05) 8.59a (p = 0.006) 0.008 (p > 0.05)
Left ERC (mm) 2.45 (0.55) 2.64 (0.62) 2.22 (0.94) 2.61 (0.39) 0.532 (p > 0.05) 3.24 (p > 0.05) 0.003 (p > 0.05)
Right ERC (mm) 2.83 (0.49) 2.61 (0.18) 2.497 (0.39) 2.91 (0.39) 0.002 (p > 0.05) 0.66 (p > 0.05) 5.934a (p = 0.02)

Covariates appearing in the model are evaluated at the following values: age = 72.56, intracranial volume = 1,343,211.69.

Key: ERC, entorhinal cortex; SD, standard deviation.

a

Denotes significance.

2.4.3. Functional neuroimaging data

We performed a set of independent voxel-wise samples t-tests in whole-brain functional activations between groups during hits and FPs. Each analysis controlled for age and ICV. In an attempt to control for type I error in all group analyses, we thresholded the individual voxels at p ≤ 0.015 and group statistical maps were corrected for multiple comparisons at the cluster level using the Analysis of Functional NeuroImage program ClustSim to protect a whole-brain probability of FPs at an overall alpha of 0.05 (Zald and Pardo, 2000). For an overall alpha level of 0.05, a cluster threshold of 21 contiguous voxels was applied.

2.4.4. Partial correlations

We performed a series of partial correlational analyses to examine associations between DRS scores and neuroimaging data. For correlations examining the association between structural measurements and DRS scores, partial correlations controlled for age and ICV. These correlations used a corrected alpha level of 0.004, which was calculated by dividing the original alpha level of 0.05 by the product of the number of groups (4) and the number of predictors (3).

If we examined the relationship between beta coefficients and DRS scores, each partial correlation controlled for age, ICV, and volume of the structure we were evaluating. These partial correlations used a corrected alpha level of 0.003, which was calculated by dividing the original alpha level of 0.05 by 16, the product of the number of groups (4) and the number of predictors (4).

3. Results

3.1. Task performance

Females demonstrated a significantly higher hit rate in run 1 when compared to males (MF = 0.605 vs. MM = 0.500, p = 0.04). The ε4 carrier group also demonstrated significantly higher hit rates in run 1 when compared to ε4 non-carriers (M+ = 0.616 vs. M = 0.501; p = 0.01).

We found no significant main effects of sex or ε4 status on run 2 hit rates or FP rates. There were also no significant interaction effects of the ε4 × sex interaction on hit or FP rates (p > 0.05). The results of this multivariate analysis of variance are summarized in Table 2.

3.2. Structural neuroimaging data

Table 3 summarizes group differences in hippocampal volume and ERC thickness. Females demonstrated significantly larger left hippocampal volumes (MF = 3156.80 vs. MM = 2823.79; p = 0.022) and right hippocampal volumes relative to males (MF = 3360.65 vs. MM = 2957.21; p = 0.006). For the right ERC thickness dependent variable, the ε4 status × sex interaction effect was statistically significant (p = 0.020). However, when simple effects tests were conducted to probe the interaction, we found no statistically significant (p > 0.0125) simple effects of ε4 status at any level of sex or of sex at any level of ε4 status.

3.3. Functional neuroimaging data

3.3.1. Hits

When functional activations of ApoE ε4 carriers were subtracted from functional activations of ApoE ε4 non-carriers during hits, no significant differences were found between groups.

When functional activations during hits of ε4 carrier females were subtracted from functional activations of ε4 carrier males, males demonstrated significantly greater activation than females in the ApoE ε4 carrier group in the anterior cingulate cortex (ACC), Brodmann’s area (BA) 10, cuneus, precuneus, middle temporal gyrus, caudate, and putamen (Fig. 1A; Supplementary Materials A).

Fig. 1.

Fig. 1.

(A) Whole-brain activation during hits when functional activation of ε4 carrier females was subtracted from ε4 carrier males. Orange indicates the areas where ε4 carrier males had greater activation compared to ε4 carrier females. (B) Whole-brain activation during false positives when functional activation of ε4 non-carriers was subtracted from ε4 carriers. Yellow indicates the areas where ε4 carriers had greater activation than ε4 non-carriers. (C) Whole-brain activation during false positives when functional activation of ε4 carrier females was subtracted from ε4 carrier males. Blue indicates the areas where ε4 carrier females had greater functional activation than ε4 carrier males.

When functional activation of ApoE ε4 non-carrier males was subtracted from ApoE ε4 non-carrier females, there were no statistically significant differences between groups.

3.3.2. False positives

When functional activations of ApoE ε4 non-carriers were subtracted from functional activations of ApoE ε4 carriers during FPs, ε4 carriers demonstrated significantly greater activation than ε4 carriers in the middle temporal gyrus, cuneus, precuneus, and right posterior cingulate cortex (PCC; Fig. 1B; Supplementary Materials B).

When functional activations of ApoE ε4 carrier females were subtracted from ApoE ε4 carrier males, females demonstrated significantly greater functional activation in areas associated with visual processing, such as the inferior and middle occipital gyrus (Fig. 1C; Supplementary Materials C).

We found no significant differences between males and females in the ε4 non-carrier group during FPs.

3.4. Partial correlational analyses: neuroimaging data

We found no significant (p > 0.004) associations between beta coefficients and DRS scores in any of the 4 groups. Male ε4 non-carriers demonstrated a significant, negative association between right hippocampal volume and DRS scores (r = −0.888, p = 0.003; Fig. 2B).

Fig. 2.

Fig. 2.

Association between right hippocampal volume (mm3) and Dementia Rating Scale scores in male ε4 non-carriers. Age and ICV were included as covariates. Abbreviation: ICV, intracranial volume.

3.5. Post hoc analyses

3.5.1. Structural neuroimaging data

We performed exploratory analyses in order to further observe differences between groups. A 2 (sex: male, female) × 2 (ε4 status: non-carrier, carrier) between-subjects MANCOVA was performed on 8 dependent variables: left/right caudate volume, left/right putamen volume, left/right isthmus cingulate thickness, and left/right parahippocampal thickness (Table 4). The MANCOVA controlled for age and ICV.

Table 4.

Post hoc structural measurements

Structural measurements Mean (SD)
F (significance)
ε4 non-carriers
ε4 carriers
 
Males (n = 10) Females (n = 11) Males (n = 9) Females (n = 9) ε4 status Sex ε4 × sex
Left caudate (mm3) 3493.60 (439.56) 3531.55 (620.92) 4170.78 (666.75) 3616.56 (486.29) 3.47 (p > 0.05) 2.02 (p > 0.05) 2.10 (p > 0.05)
Right caudate (mm3) 3492.30 (415.74) 3628.82 (960.68) 4219.78 (387.79) 3704.22 (541.19) 1.91 (p > 0.05) 0.58 (p > 0.05) 2.05 (p > 0.05)
Left putamen (mm3) 4679.30 (824.49) 4658.55 (607.08) 5502.22 (741.86) 4930.44 (620.86) 5.52a (p = 0.03) 0.96 (p > 0.05) 2.61 (p > 0.05)
Right putamen (mm3) 4424.10 (670.16) 4401.27 (668.75) 5419.67 (625.01) 4889.22 (628.16) 11.96a (p = 0.002) 1.22 (p > 0.05) 2.27 (p > 0.05)
Left parahippocampal gyrus (mm) 2.39 (0.34) 2.52 (0.35) 2.01 (0.38) 2.62 (0.44) 1.54 (p > 0.05) 9.65a (p = 0.004) 2.95 (p > 0.05)
Right parahippocampal gyrus (mm) 2.32 (0.24) 2.40 (0.36) 2.36 (0.38) 2.44 (0.16) 0.36 (p > 0.05) 0.77 (p > 0.05) 0.04 (p > 0.05)
Left isthmus cingulate gyrus (mm) 2.67 (0.21) 2.51 (0.23) 2.36 (0.15) 2.47 (0.17) 3.10a (p = 0.09) 0.57 (p > 0.05) 4.54a (p = 0.041)
Right isthmus cingulate gyrus (mm) 2.68 (0.24) 2.47 (0.35) 2.46 (0.24) 2.46 (0.19) 1.12 (p > 0.05) 0.90 (p > 0.05) 0.78 (p > 0.05)

MANCOVA controlled for age and ICV.

Key: ICV, intracranial volume; SD, standard deviation.

a

Denotes significance.

The caudate and putamen make up the dorsal striatum, which is affected by amyloid and tau pathology (Alexander et al., 1986; Beach et al., 2012; Braak and Braak, 1990; Rudelli et al., 1984). Higher plaque accumulation in the striatum was highly sensitive (95.8%) and moderately (75.7%) specific to Braak neurofibrillary tangle stage V or VI. Furthermore, a higher striatal plaque density score had 85.6% sensitivity and 86.2% specificity for the presence of dementia and clinicopathological AD (Beach et al., 2012). The parahippocampal gyrus is located in an MTL region that projects onto the hippocampus and is activated during olfactory encoding, working memory, and successful recognition memory (Cerf-Ducastel and Murphy, 2009; Haase et al., 2013; Luzzi et al., 2007; Stoub et al., 2006). The isthmus of the cingulate gyrus connects the cingulate gyrus to the parahippocampal gyrus and has shown long-term volume reduction in response to stressful life events and dementia within older populations (Calati et al., 2018; Sener, 1997; Yang et al., 2016).

Females demonstrated significantly greater thickness measurements in the left parahippocampal gyrus, relative to males (MF = 2.56 vs. MM = 2.21; p = 0.004). The ε4 carrier group, relative to the ε4 non-carriers, demonstrated significantly larger volumes in the left putamen (M+ = 5216.33 vs. M = 4668.43; p = 0.03) and right putamen (M+ = 5154.44 vs. M = 4412.14; p = 0.002).

The ε4 status × sex interaction effect was also significant (p = 0.041; Fig. 2). When simple effects were examined, male ε4 non-carriers demonstrated significantly greater thickness measurements relative to male ε4 carriers (MM = 2.666 vs. MM+ = 2.359; p = 0.002).

3.5.2. Post hoc partial correlation analyses

We performed partial correlational analyses, controlling for age and ICV, between neuroimaging data and DRS scores using the same methods described in Section 2.4.4. We found a significant, positive association between DRS scores and functional activation in the right parahippocampal gyrus during FPs in male ε4 carriers (r = 0.952, p = 0.003; Fig. 3).

Fig. 3.

Fig. 3.

Partial regression plots using age, ICV, and structure volume as covariates. Association between Dementia Rating Scale scores and functional activation in the right parahippocampal gyrus during false positives in male ε4 carriers. Abbreviation: ICV, intracranial volume.

4. Discussion

4.1. Structural neuroimaging

Our first hypothesis, that ε4 carriers would demonstrate smaller volumetric and thickness measurements in memory regions relative to ε4 non-carriers, was not upheld. We found that ε4 carriers demonstrated significantly larger bilateral putamen volumes. The larger volumetric measurements may be related to inflammation, plaque accumulation, and shape abnormalities previously associated with striatal areas (Beach et al., 2012; Braak and Braak, 1990; de Jong et al., 2008, 2011; Pievani et al., 2013; Rudelli et al., 1984). Inflammation and Aβ plaque accumulation have been suggested as possible explanations for increased thickness or volumetric measurements (Fox et al., 2005). An fluorodeoxyglucose (FDG)-positron emission tomography (PET) study found that the putamen of cognitively normal ApoE ε4 homozygotes had the highest amyloid deposition relative to other brain regions (Pardo and Lee, 2018). Similarly, another fluorodeoxyglucose (FDG)-positron emission tomography (PET) study found that amyloid deposition occurs very early in the striatum, which is comprised of the caudate and putamen, and these deposits are often not associated with clinical symptoms (Klunk et al., 2007). Furthermore, an X-ray micro-diffraction study demonstrated that there can be structural heterogeneity of amyloid such that subjects with different clinical histories may contain different ensembles of fibrillar structures (Liu et al., 2016). Polymorphism in the distribution of amyloid in plaques may be related to different disease states and variable manifestations of clinical symptoms (Liu et al., 2016; Lu et al., 2013).

The greater putamen volumes may also be attributed to neuronal compensation, which refers to a dissociation between brain pathology and behavioral change during the early and prodromal stages of neurodegenerative diseases (Gregory et al., 2017; Scheller et al., 2014). It has been proposed that in conjunction with pathological loss of brain tissue, there is a structural reorganization in the brain to compensate for these losses, which enables prodromal patients to perform functionally at the same level as those not at risk for AD (Gregory et al., 2017). It is the lack of behavioral differences between groups that indicates neuronal compensation (Gregory et al., 2017). Task performance data suggest that there were no differences between ε4 carriers and non-carriers, except for run 1, when ε4 carriers made more hits relative to ε4 non-carriers. Larger putamen volumes have also been found in other developmental or neurodegenerative disorders. When adults with autism spectrum disorder and typical developed controls were compared, the putamen was found to be significantly larger in the autism spectrum disorder group after controlling for age, sex, and ICV (Sato et al., 2014). Similarly, larger putamen volumes have been reported in individuals with bipolar disorder, schizophrenia, and obsessive-compulsive disorders (Luo et al., 2019). Hyperactivation in dopamine pathways within the striatum has been suggested to be the cause of this enlargement of the dopamine-rich putamen (Luo et al., 2019). We therefore suspect that the greater putamen volumes may be indicative of overcompensation which allows ε4 carriers to maintain functional performance in response to changes imposed by aging and ε4 status.

We found sex effects on thickness measurements in the left parahippocampal gyrus and left isthmus cingulate. Increasing asymmetry in these regions is associated with the transition of mild cognitive impairment (MCI) to AD (Long et al., 2013). A recent longitudinal study reported that when comparing ε4 carriers and ε4 non-carriers, ε4 carriers demonstrated greater rates of volume loss in the hippocampus and parahippocampal gyrus (Reiter et al., 2017). The isthmus cingulate, which connects the cingulate gyrus to the parahippocampal gyrus, was significantly reduced in ε4 carriers and in male ε4 carriers relative to ε4 non-carriers and male ε4 non-carriers, respectively (Sener,1997). This finding is supported by previous literature reporting greater atrophy and increased rate of cortical thinning in the isthmus cingulate in AD (Hayata et al., 2015; Mak et al., 2015; Vasconcelos et al., 2014).

4.2. Functional neuroimaging

Our second hypothesis, that ε4 carriers would demonstrate less functional activation during hits and greater functional activation during FPs, was partially upheld. Furthermore, we hypothesized that this activation would be especially pronounced in male ε4 carriers; this was strongly upheld. The ε4 carrier group, relative to ε4 non-carriers, and male ε4 carriers, relative to female ε4 carriers, showed greater recruitment during FPs and hits, respectively in brain regions associated with memory and decision-making (e.g., BA10, precuneus, PCC, ACC). The BA10 is an area associated with encoding the incentive value of a stimulus during decision-making and is activated by a reward stimulus when already activated by working memory processing (O’Doherty et al., 2001). The precuneus is an integral region associated with source memory retrieval and the PCC demonstrates activation during autobiographical memory retrieval (Bonnì et al., 2015; Maddock et al., 2001). Lateralization in the ACC has been activated in error processing and conflict monitoring, suggesting that the ACC is vital in making correct choices (Lütcke and Frahm, 2008).

The precuneus and PCC are not only associated with memory and information processing, but also affected early in AD progression. Hyperactivation in the left precuneus and right cingulate gyrus was found in early AD patients, relative to healthy controls, during a time representation task (Leyhe et al., 2009). During a semantic memory task, increased activation in the bilateral PCC and precuneus has been reported in asymptomatic ε4 carriers relative to controls (Seidenberg et al., 2009). Atrophy in tracts connecting the hippocampus to the precuneus and PCC differentiates normal controls from MCI and AD patients (Palesi et al., 2012). Furthermore, abnormal hypoperfusion in the PCC and precuneus distinguishes MCI patients from normal controls (Bradley et al., 2002; Rombouts et al., 2005).

It is noteworthy that despite no significant differences in FP rates, ε4 carriers demonstrated significantly greater cognitive expenditure during FPs when compared to non-carriers. Hyperactivation has been previously noted in AD populations and is often understood as a compensatory response to functional impairment and accumulating AD pathology, possibly even acting as a protective factor to help ε4 carriers maintain their cognitive abilities in the short-term (Dickerson et al., 2004; Leyhe et al., 2009; Seidenberg et al., 2009; Woodard et al., 2010). This compensatory response may occur to support task performance in response to reduced communication between brain regions that typically function together (Seidenberg et al., 2009; Zhu et al., 2015). Age-related activation increases have been correlated with poorer behavioral performance and lower white matter integrity (Zhu et al., 2015). Furthermore, excessive hyperactivation over time can lead to excitotoxicity and ultimately result in synapse degeneration and death (Mattson and Chan, 2003; Poirier et al., 1993; Woodard et al., 2010; Yanker, 1996) and has been suggested as one mechanism contributing to olfactory dysfunction in AD (Jacobson et al., 2019; Murphy, 2019). Interestingly, ApoE ε4 carrier mice show hyperactivation in olfactory areas that has been associated with olfactory deficits, suggesting that subtle, early olfactory deficits may presage future abnormalities in olfactory circuitry, and further supporting the hypothesis that hyperactivation is associated with olfactory dysfunction (East et al., 2018; Peng et al., 2017). This hyperactivation has been suggested to precede clinical symptoms in the AD pathological timeline (Gregory et al., 2017; Murphy, 2019).

4.3. Partial correlations: neuroimaging data

The third hypothesis, that neuroimaging data and DRS scores would be associated in all groups, was partially upheld. Partial correlations revealed significant associations between neuroimaging data and DRS scores within males. For male ε4 carriers, activation in the right parahippocampal gyrus was associated with higher DRS scores after age, ICV, and right parahippocampal gyrus thickness were partialed out. Higher DRS scores suggest greater global cognitive functioning (Mattis, 1998). These results support the hypothesis that hyperactivation may be protective against cognitive decline in the short term. In the male ε4 non-carrier group, larger right hippocampal volume was associated with lower DRS scores after controlling for age and ICV. This association suggests that within this sample, greater right hippocampal volume does not necessarily mean better global cognitive functioning.

5. Conclusions

The present study is the first to investigate how the interaction of sex and ApoE ε4 status impacts both structural MRI and fMRI activation during an olfactory recognition memory task in a non-demented, older population. The study demonstrates differential neuroimaging data and olfactory memory processing in relation to sex and ApoE ε4 status. No study to our knowledge has reported both structural and functional neuroimaging data within older, non-demented ε4 carriers and non-carriers during an olfactory recognition memory task. Moreover, neuroimaging studies reporting on sex differences present in olfactory recognition memory processing are lacking. Our results expand preceding literature suggesting hyperactivation patterns in those at risk for AD and provide valuable information regarding structural differences between ε4 carriers and ε4 non-carriers before AD symptoms manifest. Results suggest that prior to developing AD symptomatology, male ε4 carriers demonstrate hyperactivation during odor recognition memory relative to other groups, which may ultimately lead to future brain atrophy and decreased cognitive functioning.

There were limitations to our study. First, the study would have benefitted from larger sample sizes. Although we considered structural neuroimaging data and fMRI, we did not include data on amyloid and plaque accumulation through other imaging methods (e.g., amyloid-PET imaging, diffusion tensor imaging), which allow for examination of pre-mortem amyloid plaque burden (Hedden et al., 2013; Klunk et al., 2004). Future studies may consider these methods in conjunction with fMRI and structural MRI.

Together, our findings underscore the potential of incorporating MRI methodologies, genetics, and sex differences to identify those at risk for AD. As clinical trial research progresses to develop measures or interventions intended to slow or prevent AD clinical progression, it is imperative that we consider these factors to design interventions that are suitable, effective, and most beneficial for the population.

Supplementary Material

1

Acknowledgements

This study is supported by the National Institutes of Health (grant numbers R01AG004085-26 and R01AG062006-01) from the National Institute on Aging (to C.M.). This content is solely the responsibility of the authors and does not necessarily represent the official views of the granting agency. We would like to thank the members of the Lifespan Human Senses Laboratory for all of their assistance, especially Aaron Jacobson, Lori Haase, Erin Green, MiRan Wang, and Vincent Rupp for their contributions to data collection and analysis. We gratefully acknowledge the assistance of Dr Thomas Liu and the UCSD Center for fMRI.

Footnotes

Disclosure statement

The authors have no actual or potential conflicts of interest.

Appendix A. Supplementary data

Supplementary data to this article can be found online at https://doi.org/10.1016/j.neurobiolaging.2020.04.013.

References

  1. Albers AD, Asafu-Adjei J, Delaney MK, Kelly KE, Gomez-Isla T, Blacker D, Albers MW, 2016. Episodic memory of odors stratifies Alzheimer biomarkers in normal elderly. Ann. Neurol 80, 846–857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Albers MW, Gilmore GC, Kaye J, Murphy C, Wingfield A, Bennett DA, Zhang LI, 2015. At the interface of sensory and motor dysfunctions and Alzheimer’s disease. Alzheimers Dement. 11, 70–98. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Alexander GE, DeLong MR, Strick PL, 1986. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev. Neurosci 9, 357–381. [DOI] [PubMed] [Google Scholar]
  4. Altmann A, Tian L, Henderson VW, Greicius MD, 2014. Sex modifies the APOE-related risk of developing Alzheimer’s disease. Ann. Neurol 75, 563–573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Alzheimer’s Association, 2018. 2018 Alzheimer’s disease facts and figures. Alzheimers Dement. 14, 367–429. [Google Scholar]
  6. Attems J, Lintner F, Jellinger KA, 2005. Olfactory involvement in aging and Alzheimer’s disease: an autopsy study. J. Alzheimers Dis 7, 149–157. [DOI] [PubMed] [Google Scholar]
  7. Attems J, Neltner JH, Nelson PT, 2014. Quantitative neuropathological assessment to investigate cerebral multi-morbidity. Alzheimers Res. Ther 6, 1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bartrés-Faz D, Junqué C, Moral P, Lopez-Aldomar A, Sanchez-Aldeguer J, Clemente IC, 2002. Apolipoprotein E gender effects on cognitive performance in age-associated memory impairment. J. Neuropsychiatry Clin. Neurosci 14, 80–83. [DOI] [PubMed] [Google Scholar]
  9. Beach TG, Sue LI, Walker DG, Sabbagh MN, Serrano G, Dugger B, Souders L, 2012. Striatal amyloid plaque density predicts Braak neurofibrillary stage and clinicopathological Alzheimer’s disease: implications for amyloid imaging. J. Alzheimers Dis 28, 869–876. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Blennow K, de Leon MJ, Zetterberg H, 2006. Alzheimer’s disease. Lancet 368, 387–403. [DOI] [PubMed] [Google Scholar]
  11. Bonnì S, Veniero D, Mastropasqua C, Ponzo V, Caltagirone C, Bozzali M, Koch G, 2015. TMS evidence for a selective role of the precuneus in source memory retrieval. Behav. Brain Res 282, 70–75. [DOI] [PubMed] [Google Scholar]
  12. Braak H, Braak E, 1990. Alzheimer’s disease: striatal amyloid deposits and neurofibrillary changes. J. Neuropathol. Exp. Neurol 49, 215–224. [PubMed] [Google Scholar]
  13. Braak H, Braak E, 1996. Evolution of the neuropathology of Alzheimer’s disease. Acta Neurol. Scand 94, 3–12. [DOI] [PubMed] [Google Scholar]
  14. Braak H, Braak E, 1997. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging 18, 351–357. [DOI] [PubMed] [Google Scholar]
  15. Braak H, Braak E, 1991. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239–259. [DOI] [PubMed] [Google Scholar]
  16. Bradley KM, O’Sullivan VT, Soper NDW, Nagy Z, King EM-F, Smith AD, Shepstone BJ, 2002. Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer’s disease. Brain 125, 1772–1781. [DOI] [PubMed] [Google Scholar]
  17. Bu G, 2009. Apolipoprotein E and its receptors in Alzheimer’s disease: pathways, pathogenesis and therapy. Nat. Rev. Neurosci 10, 333–344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Calati R, Maller JJ, Meslin C, Lopez-Castroman J, Ritchie K, Courtet P, Artero S, 2018. Repatriation is associated with isthmus cingulate cortex reduction in community-dwelling elderly. World J. Biol. Psychiatry 19, 421–430. [DOI] [PubMed] [Google Scholar]
  19. Calhoun-Haney R, Murphy C, 2005. Apolipoprotein ε4 is associated with more rapid decline in odor identification than in odor threshold or Dementia Rating Scale scores. Brain Cogn. 58, 178–182. [DOI] [PubMed] [Google Scholar]
  20. Cerf-Ducastel B, Murphy C, 2009. Age-related differences in the neural substrates of cross-modal olfactory recognition memory: an fMRI investigation. Brain Res. 1285, 1–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Cerf-Ducastel B, Murphy C, 2006. Neural substrates of cross-modal olfactory recognition memory: an fMRI study. Neuroimage 31, 386–396. [DOI] [PubMed] [Google Scholar]
  22. Chen J, Shu H, Wang Z, Liu D, Shi Y, Xu L, Zhang Z, 2016. Protective effect of APOE epsilon 2 on intrinsic functional connectivity of the entorhinal cortex is associated with better episodic memory in elderly individuals with risk factors for Alzheimer’s disease. Oncotarget 7, 58789–58801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Chen Y, Chen K, Zhang J, Li X, Shu N, Wang J, Reiman EM, 2015. Disrupted functional and structural networks in cognitively normal elderly subjects with the APOE ε4 allele. Neuropsychopharmacology 40, 1181–1191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Cox RW, 1996. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput. Biomed. Res 29, 162–173. [DOI] [PubMed] [Google Scholar]
  25. Cox RW, Hyde JS, 1997. Software tools for analysis and visualization of FMRI data. NMR Biomed. 10, 171–178. [DOI] [PubMed] [Google Scholar]
  26. Dale AM, Fischl B, Sereno MI, 1999. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 9, 179–194. [DOI] [PubMed] [Google Scholar]
  27. Dale AM, Sereno MI, 1993. Improved localization of cortical activity by combining EEG and MEG with MRI cortical surface reconstruction: a linear approach. J. Cogn. Neurosci 5, 162–176. [DOI] [PubMed] [Google Scholar]
  28. de Jong LW, Ferrarini L, Van der Grond J, Milles JR, Reiber JHC, Westendorp RGJ, Buchem M.A. van., 2011. Shape abnormalities of the striatum in Alzheimer’s disease. J. Alzheimers Dis 23, 49–59. [DOI] [PubMed] [Google Scholar]
  29. de Jong LW, van der Hiele K, Veer IM, Houwing JJ, Westendorp RGJ, Bollen ELEM, van der Grond J, 2008. Strongly reduced volumes of putamen and thalamus in Alzheimer’s disease: an MRI study. Brain 131, 3277–3285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Desikan RS, Ségonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, Killiany RJ, 2006. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31, 968–980. [DOI] [PubMed] [Google Scholar]
  31. Dickerson BC, Salat DH, Bates JF, Atiya M, Killiany RJ, Greve DN, Sperling RA, 2004. Medial temporal lobe function and structure in mild cognitive impairment. Ann. Neurol 56, 27–35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Dowell NG, Evans SL, Tofts PS, King SL, Tabet N, Rusted JM, 2016. Structural and resting-state MRI detects regional brain differences in young and mid-age healthy APOE-e4 carriers compared with non-APOE-e4 carriers. NMR Biomed. 29, 614–624. [DOI] [PubMed] [Google Scholar]
  33. East BS, Fleming G, Peng K, Olofsson JK, Levy E, Mathews PM, Wilson DA, 2018. Human apolipoprotein E genotype differentially affects olfactory behavior and sensory physiology in mice. Neuroscience 1, 103–110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Esiri MM, Wilcock GK, 1984. The olfactory bulbs in Alzheimer’s disease. J. Neurol. Neurosurg. Psychiatry 47, 56–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, van Dujin CM, 1997. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA 278, 1349. [PubMed] [Google Scholar]
  36. Filippini N, MacIntosh BJ, Hough MG, Goodwin GM, Frisoni GB, Smith SM, Mackay CE, 2009. Distinct patterns of brain activity in young carriers of the APOE-4 allele. Proc. Natl. Acad. Sci. U. S. A 106, 7209–7214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Fischl B, Dale AM, 2000. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc. Natl. Acad. Sci. U. S. A 97, 11050–11055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Fischl B, Liu A, Dale AM, 2001. Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex. IEEE Trans. Med. Imaging 20, 70–80. [DOI] [PubMed] [Google Scholar]
  39. Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, Dale AM, 2002. Whole brain segmentation. Neuron 33, 341e355. [DOI] [PubMed] [Google Scholar]
  40. Fischl B, Salat DH, van der Kouwe AJW, Makris N, Ségonne F, Quinn BT, Dale AM, 2004a. Sequence-independent segmentation of magnetic resonance images. Neuroimage 23, S69–S84. [DOI] [PubMed] [Google Scholar]
  41. Fischl B, Sereno MI, Dale AM, 1999a. Cortical surface-based analysis II: inflation, flattening, and a surface-based coordinate system. Neuroimage 9, 195–207. [DOI] [PubMed] [Google Scholar]
  42. Fischl B, Sereno MI, Tootell RB, Dale AM, 1999b. High-resolution intersubject averaging and a coordinate system for the cortical surface. Hum. Brain Mapp 8, 272–284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Fischl B, van der Kouwe A, Destrieux C, Halgren E, Segonne F, Salat DH, Busa E, Seidman LJ, Goldstein J, Kennedy D, Caviness V, Makris N, Rosen B, Dale AM, 2004b. Automatically parcellating the human cerebral cortex. Cereb. Cortex 14, 11–22. [DOI] [PubMed] [Google Scholar]
  44. Fox NC, Black RS, Gilman S, Rossor MN, Griffith SG, Jenkins L, for the AN1792(QS-21)-201 Study Team, 2005. Effects of Ab immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease. Neurology 64, 1563–1572. [DOI] [PubMed] [Google Scholar]
  45. Frisoni GB, Fox NC, Jack CR, Scheltens P, Thomson PM, 2010. The clinical use of structural MRI in Alzheimer disease. Nat. Rev. Neurol 6, 67–77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Gilbert PE, Murphy C, 2004. The effect of the ApoE ε4 allele on recognition memory for olfactory and visual stimuli in patients with pathologically confirmed Alzheimer’s disease, probable Alzheimer’s disease, and healthy elderly controls. J. Clin. Exp. Neuropsychol 26, 779–794. [DOI] [PubMed] [Google Scholar]
  47. Gold S, Christian B, Arndt S, Zeien G, Cizadlo T, Johnson DL, Flaum M, Andreasen NC, 1998. Functional MRI statistical software packages: a comparative analysis. Hum. Brain Mapp 6, 73–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Gregory S, Long JD, Klöppel S, Razi A, Scheller E, Minkova L, Rees G, 2017. Operationalizing compensation over time in neurodegenerative disease. Brain 140, 1158–1165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Haase L, Wang M, Green E, Murphy C, 2013. Functional connectivity during recognition memory in individuals genetically at risk for Alzheimer’s disease.Hum. Brain Mapp. 34, 530–542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Han X, Jovicich J, Salat D, van der Kouwe A, Quinn B, Czanner S, Busa E, Pacheco J, Albert M, Killiany R, Maguire P, Rosas D, Makris N, Dale A, Dickerson B, Fischl B, 2006. Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade and manufacturer. Neuroimage 32, 180–194. [DOI] [PubMed] [Google Scholar]
  51. Hayata TT, Bergo FPG, Rezende TJ, Damasceno A, Damasceno BP, Cendes F, Balthazar MLF, 2015. Cortical correlates of affective syndrome in dementia due to Alzheimer’s disease. Arq. Neuropsiquiatr 73, 553–560. [DOI] [PubMed] [Google Scholar]
  52. Hedden T, Oh H, Younger AP, Patel TA, 2013. Meta-analysis of amyloidcognition relations in cognitively normal older adults. Neurology 80, 1341–1348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Holland D, Desikan RS, Dale AM, McEvoy LK, 2013. Higher rates of decline for women and apolipoprotein E ε4 carriers. Am. J. Neuroradiol 34, 2287–2293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Hyman BT, 1997. The neuropathological diagnosis of Alzheimer’s disease: clinicalpathological studies. Neurobiol. Aging 18, S27–S32. [DOI] [PubMed] [Google Scholar]
  55. Hyman BT, Gomez-Isla T, Briggs M, Chung H, Nichols S, Kohout F, Wallace R, 1996. Apolipoprotein E and cognitive change in an elderly population. Ann. Neurol 40, 55–66. [DOI] [PubMed] [Google Scholar]
  56. Jacobson A, Green E, Haase L, Szajer J, Murphy C, 2019. Differential effects of BMI on brain response to odor in olfactory, reward and memory regions: evidence from fMRI. Nutrients 11, 926. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Jovicich J, Czanner S, Greve D, Haley E, van der Kouwe A, Gollub R, Kennedy D, Schmitt F, Brown G, Macfall J, Fischl B, Dale A, 2006. Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data. Neuroimage 30, 436–443. [DOI] [PubMed] [Google Scholar]
  58. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Långström B, 2004. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B. Ann. Neurol 55, 306–319. [DOI] [PubMed] [Google Scholar]
  59. Klunk WE, Price JC, Mathis CA, Tsopelas ND, Lopresti BJ, Ziolko SK, DeKosky ST, 2007. Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J. Neurosci 27, 6174–6184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Kuperberg GR, Broome MR, McGuire PK, David AS, Eddy M, Ozawa F, Williams SCR, 2003. Regionally localized thinning of the cerebral cortex in schizophrenia. Arch. Gen. Psychiatry 60, 11. [DOI] [PubMed] [Google Scholar]
  61. Leyhe T, Erb M, Milian M, Eschweiler GW, Ethofer T, Grodd W, Saur R, 2009. Changes in cortical activation during retrieval of clock time representations in patients with mild cognitive impairment and early Alzheimer’s disease. Dement. Geriatr. Cogn. Disord. 27, 117–132. [DOI] [PubMed] [Google Scholar]
  62. Lind J, Persson J, Ingvar M, Larsson A, Cruts M, Van Broeckhoven C, Nyberg L, 2006. Reduced functional brain activity response in cognitively intact apolipoprotein E ε4 carriers. Brain 129, 1240–1248. [DOI] [PubMed] [Google Scholar]
  63. Liu J, Costantino I, Venugopalan N, Fischetti RF, Hyman BT, Frosch MP, Makowski L, 2016. Amyloid structure exhibits polymorphism on multiple length scales in human brain tissue. Sci. Rep 6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Long X, Zhang L, Liao W, Jiang C, Qiu B, 2013. Distinct laterality alterations distinguish mild cognitive impairment and Alzheimer’s disease from healthy aging: statistical parametric mapping with high resolution MRI. Hum. Brain Mapp 34, 3400–3410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Lu J-X, Qiang W, Yau W-M, Schwieters CD, Meredith SC, Tycko R, 2013. Molecular structure of b-amyloid fibrils in Alzheimer’s disease brain tissue. Cell 154, 1257–1268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Luo X, Mao Q, Shi J, Wang X, Li C-SR, 2019. Putamen gray matter volumes in neuropsychiatric and neurodegenerative disorders. World J. Psychiatry Ment. Health Res 3. [PMC free article] [PubMed] [Google Scholar]
  67. Lütcke H, Frahm J, 2008. Lateralized anterior cingulate function during error processing and conflict monitoring as revealed by high-resolution fMRI. Cereb. Cortex 18, 508–515. [DOI] [PubMed] [Google Scholar]
  68. Luzzi S, Snowden JS, Neary D, Coccia M, Provinciali L, Lambon Ralph MA, 2007. Distinct patterns of olfactory impairment in Alzheimer’s disease, semantic dementia, frontotemporal dementia, and corticobasal degeneration. Neuropsychologia 45, 1823–1831. [DOI] [PubMed] [Google Scholar]
  69. Maddock RJ, Garrett AS, Buonocore MH, 2001. Remembering familiar people: the posterior cingulate cortex and autobiographical memory retrieval. Neuroscience 104, 667–676. [DOI] [PubMed] [Google Scholar]
  70. Mahley RW, Huang Y, 2012. Apolipoprotein E sets the stage: response to injury triggers neuropathology. Neuron 76, 871–885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Mahley RW, Rall SC, 2000. Apolipoprotein E: far more than a lipid transport protein. Annu. Rev. Genomics Hum. Genet 1, 507–537. [DOI] [PubMed] [Google Scholar]
  72. Mak E, Su L, Williams GB, Watson R, Firbank MJ, Blamire AM, O’Brien JT, 2015. Progressive cortical thinning and subcortical atrophy in dementia with Lewy bodies and Alzheimer’s disease. Neurobiol. Aging 36, 1743–1750. [DOI] [PubMed] [Google Scholar]
  73. Mattis S, 1988. Dementia Rating Scale (DRS) Professional Manual. Psychological Assessment Resources, Inc, Odessa, FL. [Google Scholar]
  74. Mattson MP, Chan SL, 2003. Neuronal and glial calcium signaling in Alzheimer’s disease. Cell Calcium 34, 385–397. [DOI] [PubMed] [Google Scholar]
  75. Moberg PJ, Pearlson GD, Speedie LJ, Lipsey JR, Strauss ME, Folstein SE, 1987. Olfactory recognition: differential impairments in early and late Huntington’s and Alzheimer’s diseases. J. Clin. Exp. Neuropsychol 9, 650–664. [DOI] [PubMed] [Google Scholar]
  76. Mondadori CRA, de Quervain DJ-F, Buchmann A, Mustovic H, Wollmer MA, Schmidt CF, Henke K, 2007. Better memory and neural efficiency in young apolipoprotein E 4 carriers. Cereb. Cortex 17, 1934–1947. [DOI] [PubMed] [Google Scholar]
  77. Murphy C, 2019. Olfactory and other sensory impairments in Alzheimer disease. Nat. Rev. Neurol 15, 11–24. [DOI] [PubMed] [Google Scholar]
  78. Murphy C, Gilmore MM, Seery CS, Salmon DP, Lasker BR, 1990. Olfactory thresholds are associated with degree of dementia in Alzheimer’s disease. Neurobiol. Aging 11, 465–469. [DOI] [PubMed] [Google Scholar]
  79. Murphy C, Jernigan TL, Fennema-Notestine C, 2003. Left hippocampal volume loss in Alzheimer’s disease is reflected in performance on odor identification: a structural MRI study. J. Int. Neuropsychol. Soc 9. [DOI] [PubMed] [Google Scholar]
  80. Murphy C, Nordin S, Acosta L, 1997. Odor learning, recall, and recognition memory in young and elderly adults. Neuropsychology 11, 126–137. [DOI] [PubMed] [Google Scholar]
  81. Murphy C, Nordin S, Jinich S, 1999. Very early decline in recognition memory for odors in Alzheimer’s disease. Aging Neuropsychol. Cogn 6, 229–240. [Google Scholar]
  82. Murphy C, Schubert CR, Cruickshanks KJ, Klein BEK, Klein R, Nondahl DM, 2002. Prevalence of olfactory impairment in older adults. JAMA 288, 2307. [DOI] [PubMed] [Google Scholar]
  83. Nordin S, Murphy C, 1996. Impaired sensory and cognitive olfactory function in questionable Alzheimer’s disease. Neuropsychology 10, 113–119. [Google Scholar]
  84. Nordin S, Murphy C, 2006. Odor memory in normal aging and Alzheimer’s disease. Ann. N. Y. Acad. Sci 855, 686–693. [DOI] [PubMed] [Google Scholar]
  85. O’Doherty J, Kringelbach ML, Rolls ET, Hornak J, Andrews C, 2001. Abstract reward and punishment representations in the human orbitofrontal cortex. Nat. Neurosci 4, 95–102. [DOI] [PubMed] [Google Scholar]
  86. Olofsson JK, Nordin S, Wiens S, Hedner M, Nilsson L-G, Larson M, 2010. Odor identification impairment in carriers of ApoE-e4 is independent of clinical dementia. Neurobiol. Aging 31, 567–577. [DOI] [PubMed] [Google Scholar]
  87. Palesi F, Vitali P, Chiarati P, Castellazzi G, Caverzasi E, Pichiecchio A, Bastianello S, 2012. DTI and MR volumetry of hippocampus-PC/PCC circuit: in search of early micro- and macrostructural signs of Alzheimer’s disease. Neurol. Res. Int 2012, 1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Pardo JV, Lee JT, 2018. Atypical localization and dissociation between glucose uptake and amyloid deposition in cognitively normal APOE*E4 homozygotic elders compared with patients with late-onset Alzheimer’s disease. eNeuro 5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Payami H, Zareparsi S, Montee KR, Sexton GJ, Kaye JA, Bird TD, Schellenberg GD, 1996. Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. Am. J. Hum. Genet 58, 803–811. [PMC free article] [PubMed] [Google Scholar]
  90. Peng KY, Mathews PM, Levy E, Wilson DA, 2017. Apolipoprotein E4 causes early olfactory network abnormalities and short-term olfactory memory impairments. Neuroscience 20, 364–371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Pievani M, Bocchetta M, Boccardi M, Cavedo E, Bonetti M, Thompson PM, Frisoni GB, 2013. Striatal morphology in early-onset and late-onset Alzheimer’s disease: a preliminary study. Neurobiol. Aging 34, 1728–1739. [DOI] [PubMed] [Google Scholar]
  92. Poirier J, Bertrand P, Poirier J, Kogan S, Gauthier S, Poirier J, Davignon J, 1993. Apolipoprotein E polymorphism and Alzheimer’s disease. Lancet 342, 697–699. [DOI] [PubMed] [Google Scholar]
  93. Price JL, Davis PB, Morris JC, White DL, 1991. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer’s disease. Neurobiol. Aging 12, 295–312. [DOI] [PubMed] [Google Scholar]
  94. Reiter K, Nielson KA, Durgerian S, Woodard JL, Smith JC, Seidenberg M, Rao SM, 2017. Five-year longitudinal brain volume change in healthy elders at genetic risk for Alzheimer’s disease. J. Alzheimers Dis 55, 1363–1377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Reuter M, Fischl B, 2011. Avoiding asymmetry-induced bias in longitudinal image processing. Neuroimage 57, 19–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Reuter M, Rosas HD, Fischl B, 2010. Highly accurate inverse consistent registration: a robust approach. Neuroimage 53, 1181–1196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Reuter M, Schmansky NJ, Rosas HD, Fischl B, 2012. Within-subject template estimation for unbiased longitudinal image analysis. Neuroimage 61, 1402–1418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Rombouts SARB, Barkhof F, Goekoop R, Stam CJ, Scheltens P, 2005. Altered resting state networks in mild cognitive impairment and mild Alzheimer’s disease: an fMRI study. Hum. Brain Mapp 26, 231–239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Rosas HD, Liu AK, Hersch S, Glessner M, Ferrante RJ, Salat DH, van der Kouwe A, Jenkins BG, Dale AM, Fischl B, 2002. Regional and progressive thinning of the cortical ribbon in Huntington’s disease. Neurology 58, 695–701. [DOI] [PubMed] [Google Scholar]
  100. Rudelli RD, Ambler MW, Wisniewski HM, 1984. Morphology and distribution of Alzheimer neuritic (senile) and amyloid plaques in striatum and diencephalon. Acta Neuropathol. 64, 273–281. [DOI] [PubMed] [Google Scholar]
  101. Salat DH, Buckner RL, Snyder AZ, Greve DN, Desikan RSR, Busa E, Fischl B, 2004. Thinning of the cerebral cortex in aging. Cereb. Cortex 14, 721–730. [DOI] [PubMed] [Google Scholar]
  102. Sato W, Kubota Y, Kochiyama T, Uono S, Yoshimura S, Sawada R, Toichi M, 2014. Increased putamen volume in adults with autism spectrum disorder. Front. Hum. Neurosci 8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Scheller E, Minkova L, Leitner M, Klöppel S, 2014. Attempted and successful compensation in preclinical and early manifest neurodegenerationda review of task fMRI studies. Front. Psychiatry 5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Ségonne F, Dale AM, Busa E, Glessner M,Salat D, Hahn HK, Fischl B, 2004. A hybrid approach to the skull stripping problem in MRI. Neuroimage 22, 1060–1075. [DOI] [PubMed] [Google Scholar]
  105. Ségonne F, Pacheco J, Fischl B, 2007. Geometrically accurate topology-correction of cortical surfaces using nonseparating loops. IEEE Trans. Med. Imaging 26, 518–529. [DOI] [PubMed] [Google Scholar]
  106. Seidenberg M, Guidotti L, Nielson KA, Woodard JL, Durgerian S, Antuono P, Rao SM, 2009. Semantic memory activation in individuals at risk for developing Alzheimer disease. Neurology 73, 612–620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Sener RN, 1997. Large isthmus of the cingulate gyrus: an unusual anatomical variation simulating tumor. Comput. Med. Imaging Graph 21, 337–339. [DOI] [PubMed] [Google Scholar]
  108. Ship JA, Pearson JD, Cruise LJ, Brant LJ, Metter EJ, 1996. Longitudinal changes in smell identification. J. Gerontol. A. Biol. Sci. Med. Sci 51A, M86–M91. [DOI] [PubMed] [Google Scholar]
  109. Sled JG, Zijdenbos AP, Evans AC, 1998. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans. Med. Imaging 17, 87–97. [DOI] [PubMed] [Google Scholar]
  110. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TEJ, Johansen-Berg H, Matthews PM, 2004. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23, S208–S219. [DOI] [PubMed] [Google Scholar]
  111. Stark CEL, Squire LR, 2000a. FMRI activity in the medial temporal lobe during recognitionmemoryasafunctionofstudy-testinterval. Hippocampus 10,329–337. [DOI] [PubMed] [Google Scholar]
  112. Stark CEL, Squire LR, 2000b. Functional magnetic resonance imaging (fMRI) activity in the hippocampal region during recognition memory. J. Neurosci 20, 7776–7781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Stoub TR, deToledo-Morrell L, Stebbins GT, Leurgans S, Bennett DA, Shah RC, 2006. Hippocampal disconnection contributes to memory dysfunction in individuals at risk for Alzheimer’s disease. Proc. Natl. Acad. Sci. U. S. A 103, 10041–10045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Ungar L, Altmann A, Greicius MD, 2014. Apolipoprotein E, gender, and Alzheimer’s disease: an overlooked, but potent and promising interaction. Brain Imaging Behav. 8, 262–273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Vasconcelos L. de G, Jackowski AP, de Oliveira MO, Flor YMR, Souza AAL, Bueno OFA, Brucki SMD, 2014. The thickness of posterior cortical areas is related to executive dysfunction in Alzheimer’s disease. Clinics 69, 28–37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. Visser P, Verhey F, Hofman P, Scheltens P, Jolles J, 2002. Medial temporal lobe atrophy predicts Alzheimer’s disease in patients with minor cognitive impairment. J. Neurol. Neurosurg. Psychiatry 72, 491–497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Wehling EI, Lundervold AJ, Nordin S, Wollschlaeger D, 2016. Longitudinal changes in familiarity, free and cued odor identification, and edibility judgments for odors in aging individuals. Chem. Senses 41, 155–161. [DOI] [PubMed] [Google Scholar]
  118. Woodard JL, Seidenberg M, Nielson KA, Smith JC, Antuono P, Durgerian S, Rao SM, 2010. Prediction of cognitive decline in healthy older adults using fMRI. J. Alzheimers Dis 21, 871–885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Yang Z, Wen W, Jiang J, Crawford JD, Reppermund S, Levitan C, Sachdev PS, 2016. MRI markers of dementia in the eighth to eleventh decades of life. Alzheimers Dement. 12, P334–P335. [Google Scholar]
  120. Yanker BA, 1996. Mechanisms of neuronal degeneration in Alzheimer’s disease. Neuron 16, 921–932. [DOI] [PubMed] [Google Scholar]
  121. Yu L, Boyle P, Schneider JA, Segawa E, Wilson RS, Leurgans S, Bennett DA, 2013. APOE ε4, Alzheimer’s disease pathology, cerebrovascular disease, and cognitive change over the years prior to death. Psychol. Aging 28, 1015–1023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Zald DH, Pardo JV, 2000. Functional neuroimaging of the olfactory system in humans. Int. J. Psychophysiol 36, 165–181. [DOI] [PubMed] [Google Scholar]
  123. Zhu Z, Johnson NF, Kim C, Gold BT, 2015. Reduced frontal cortex efficiency is associated with lower white matter integrity in aging. Cereb. Cortex 25, 138–146. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1

RESOURCES